XJPX3583
Market cap21mUSD
Dec 26, Last price
1,208.00JPY
1D
0.17%
1Q
1.60%
Jan 2017
-15.82%
Name
AuBEX Corp
Chart & Performance
P/E
7.69
P/S
0.62
EPS
157.18
Div Yield, %
1.84%
Shrs. gr., 5y
—
Rev. gr., 5y
1.46%
Revenues
5.39b
+1.35%
Net income
436m
-6.98%
CFO
1.05b
+211.75%
Dividend
Mar 28, 20250 JPY/sh
Profile
AuBEX CORPORATION manufactures and sells nibs and medical equipment in Japan and internationally. The company offers nibs made from polyester fibers, nylon fibers, acrylic fibers, plastics, and engineering plastics for stationery used in writing, marking, painting, and presentation, as well as for PC peripherals and industrial equipment; and nibs for makeup and cosmetics products, including porous tips and PBT brush tips, feeders, and cosmetics tips. It also provides medical equipment and components, such as pressure infusion devices and angiography guide wires for public and private university hospitals, and other hospitals. The company was formerly known as Tokyo hat Co., Ltd. and changed its name to AuBEX CORPORATION in 1985. AuBEX CORPORATION was founded in 1892 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | |||||
Revenues | 5,387,010 1.35% | 5,315,220 -3.12% | 5,486,187 15.46% | ||
Cost of revenue | 4,790,276 | 4,756,112 | 4,852,704 | ||
Unusual Expense (Income) | |||||
NOPBT | 596,734 | 559,108 | 633,483 | ||
NOPBT Margin | 11.08% | 10.52% | 11.55% | ||
Operating Taxes | 163,955 | 211,604 | 189,228 | ||
Tax Rate | 27.48% | 37.85% | 29.87% | ||
NOPAT | 432,779 | 347,504 | 444,255 | ||
Net income | 436,435 -6.98% | 469,191 -12.55% | 536,508 366.67% | ||
Dividends | (61,613) | (76,912) | (46,199) | ||
Dividend yield | 2.27% | 2.70% | 1.83% | ||
Proceeds from repurchase of equity | (48) | (113) | |||
BB yield | 0.00% | 0.00% | |||
| Debt | |||||
Debt current | 709,650 | 657,133 | 1,146,603 | ||
Long-term debt | 1,182,906 | 1,580,955 | 1,257,749 | ||
Deferred revenue | 547,153 | (41,491) | |||
Other long-term liabilities | 563,698 | 520 | 524,792 | ||
Net debt | (1,191,367) | (351,772) | (183,978) | ||
| Cash flow | |||||
Cash from operating activities | 1,054,683 | 338,314 | 1,000,897 | ||
CAPEX | (143,000) | (274,585) | (168,324) | ||
Cash from investing activities | (164,645) | (183,548) | (189,449) | ||
Cash from financing activities | (450,598) | (205,903) | (265,566) | ||
FCF | 748,935 | (31,979) | 679,535 | ||
| Balance | |||||
Cash | 2,952,548 | 2,476,067 | 2,499,229 | ||
Long term investments | 131,375 | 113,793 | 89,101 | ||
Excess cash | 2,814,572 | 2,324,099 | 2,314,021 | ||
Stockholders' equity | 5,750,000 | 5,522,164 | 5,111,374 | ||
Invested Capital | 5,845,498 | 6,213,890 | 5,752,387 | ||
ROIC | 7.18% | 5.81% | 7.56% | ||
ROCE | 6.87% | 6.53% | 7.81% | ||
| EV | |||||
Common stock shares outstanding | 2,783 | 2,774 | 2,765 | ||
Price | 976.00 -5.06% | 1,028.00 12.35% | 915.00 38.43% | ||
Market cap | 2,716,556 -4.72% | 2,851,186 12.70% | 2,529,932 38.50% | ||
EV | 1,525,189 | 2,499,414 | 2,345,954 | ||
EBITDA | 866,277 | 850,699 | 917,726 | ||
EV/EBITDA | 1.76 | 2.94 | 2.56 | ||
Interest | 15,736 | 13,611 | 14,625 | ||
Interest/NOPBT | 2.64% | 2.43% | 2.31% | ||